...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Differences of Opinion
5
May 24, 2016 10:55AM
4
May 24, 2016 11:48AM

RVX got as high as 29.50 long before they even started a Phase I trial.


May 24, 2016 02:55PM
8
May 24, 2016 04:25PM
2
May 24, 2016 06:59PM
1
May 24, 2016 10:59PM
4
May 24, 2016 11:43PM
1
May 24, 2016 11:48PM
Share
New Message
Please login to post a reply